Calvin Sternick

Stock Analyst at JP Morgan

(2.03)
# 3,055
Out of 5,134 analysts
19
Total ratings
46.15%
Success rate
7.43%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $86.54
Upside: +27.11%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $41.23
Upside: +94.03%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $41.01
Upside: -34.16%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $235.12
Upside: -22.59%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $234.25
Upside: -65.42%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $135.68
Upside: +188.92%